Pathology Asia Holdings Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 6

  • Investments
  • 10

Pathology Asia Holdings General Information

Description

Provider of clinical diagnostic services intended to support medical decision-making and patient outcomes. The company utilizes clinical grade genetic testing, genomics services, toxicology laboratories, a digital health ecosystem, specimen transport logistics and on-site screening, enabling hospitals and healthcare providers to access accurate laboratory data for patient care.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 15 Jalan Kilang Barat, Frontech Centre
  • Level Number 06-04
  • Singapore, 159357
  • Singapore
Primary Industry
Laboratory Services (Healthcare)
Vertical(s)
Corporate Office
  • 15 Jalan Kilang Barat, Frontech Centre
  • Level Number 06-04
  • Singapore, 159357
  • Singapore

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pathology Asia Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pathology Asia Holdings‘s full profile, request access.

Request a free trial

Pathology Asia Holdings Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pathology Asia Holdings‘s full profile, request access.

Request a free trial

Pathology Asia Holdings Investments (10)

Pathology Asia Holdings’s most recent deal was a Early Stage VC with Naluri for . The deal was made on 09-Jun-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Naluri 09-Jun-2021 Early Stage VC Clinics/Outpatient Services
ClearNote Health 12-May-2021 Later Stage VC Drug Discovery
Singapore Diagnostics 01-Jan-2021 Buyout/LBO Laboratory Services (Healthcare)
Tissupath 01-Jan-2021 Buyout/LBO Laboratory Services (Healthcare)
Advanced Genomics 01-Jan-2020 Buyout/LBO Laboratory Services (Healthcare)
You’re viewing 5 of 10 investments. Get the full list »

Pathology Asia Holdings Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
Singapore Diagnostics Pasig, Philippines 2013
Safework Health Mount Waverley, Australia 2012
Quantum Diagnostics (Malaysia) Petaling Jaya, Malaysia 2011
Tissupath Mount Waverley, Australia 2004
Innoquest Pathology Petaling Jaya, Malaysia 1996

Pathology Asia Holdings FAQs

  • When was Pathology Asia Holdings founded?

    Pathology Asia Holdings was founded in 2018.

  • Where is Pathology Asia Holdings headquartered?

    Pathology Asia Holdings is headquartered in Singapore, Singapore.

  • What industry is Pathology Asia Holdings in?

    Pathology Asia Holdings’s primary industry is Laboratory Services (Healthcare).

  • Is Pathology Asia Holdings a private or public company?

    Pathology Asia Holdings is a Private company.

  • What is Pathology Asia Holdings’s current revenue?

    The current revenue for Pathology Asia Holdings is .

  • Who are Pathology Asia Holdings’s investors?

    TPG has invested in Pathology Asia Holdings.

  • When was Pathology Asia Holdings acquired?

    Pathology Asia Holdings was acquired on 23-Sep-2026.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process